1. Home
  2. Advocacy
  3. Latest News and Practice Data
  4. Previous Advocacy Updates

Previous Advocacy Updates

  • March 26, 2020

    The CMS granted the CAP’s request for a temporary waiver giving pathologists the flexibility needed to work remotely during the COVID-19 pandemic.

  • March 23, 2020

    The CAP urged the CMS and engaged with Congress to allow pathologists and laboratory personnel to work remotely during the COVID-19 pandemic.

  • March 17, 2020

    The Centers for Medicare & Medicaid Services (CMS) informed the CAP that it will suspend mandatory CLIA inspections for laboratories for a period of three weeks.

  • March 10, 2020

    The CDC strongly encouraged clinical laboratories that are developing and implementing their own COVID-19 tests to contact their state public health department first.

  • March 3, 2020

    The FDA issued guidance to expand testing capacity by facilitating the development of molecular SARS-CoV-2 diagnostic assays (coronavirus).

  • February 25, 2020

    Join state pathology leaders from across the country at the Pathologist Leadership Summit, May 2-5, 2020 on this page.

  • February 18, 2020

    The House Ways & Means Committee overwhelmingly voted to support the CAP-backed Consumer Protections Against Surprise Medical Bills Act of 2020 to resolve billing disputes between insurers and physicians.

  • February 11, 2020

    The House Ways and Means Committee released legislation that features provisions advocated for by the CAP to resolve billing disputes between insurers and physicians.

  • February 4, 2020

    The CAP urged CMS to consider the complexity of pathology practice when requiring group health plans to disclose price and cost-sharing information.

  • January 28, 2020

    The CAP, the AMA, and ten other physician groups engaged with Congress on developing bipartisan legislation that will protect patients from surprise bills and safeguard access to care.

  • January 21, 2020

    The CAP and the AMA took issue with proposed scope of practice policy changes and their potential adverse impacts on the quality of patient care.

  • January 14, 2020

    Solutions provided by the CAP allowed pathologists to prevent a -5% penalty to their Medicare reimbursement in 2020.

  • January 7, 2020

    The CAP urged the CMS to adjust several proposed changes to the Medicare physician self-referral law, commonly referred to as the Stark law.

  • December 24, 2019

    Before going to recess for 2019, Congress passed a $1.4 trillion spending package for 2020 and listened to the CAP’s concerns regarding rates for out-of-network care.

  • December 17, 2019

    While Congress debated how to address surprise medical bills, the CAP mobilized pathologists to engage representatives and senators to ensure our views were heard.

  • December 10, 2019

    The CAP urges Congress to address reimbursement for physician out-of-network services while it moves swiftly on surprise bills legislation.

  • November 26, 2019

    The CAP opposed a Horizon BlueCross BlueShield of NJ reimbursement policy that limits on units for surgical pathology and microscopic examination services.

  • November 19, 2019

    At the 2019 AMA Interim Meeting, the CAP advocated to reinstate autopsy hospital standard and pushes back on step therapy protocols.

  • November 12, 2019

    The CAP participated at the Clinical Laboratory Improvement Advisory Committee and sought to ensure regulations keep up with emerging technologies.

  • November 5, 2019

    The CAP, the American Medical Association, and 100 other medical societies raised concerns in a recent letter to the Secretary of the Department of Health and Human Services regarding a proposal to loosen current Medicare scope of practice restraints.

Analysis of Final 2020 Medicare Rule

Read the special report Right Arrow

Direct questions or comments to:

advocacyupdate@cap.org

202-354-7100

  1. Left Arrow
  2. 3
  3. 4
  4. 5
  5. 6
  6. 7
  7. 8
  8. 9
  9. 10
  10. 11
  11. 12
  12. Right Arrow
Viewing 121-140 of 304